| Clinical management of primary aldosteronism: an update GP Rossi, FB Rossi, C Guarnieri, G Rossitto, TM Seccia Hypertension 81 (9), 1845-1856, 2024 | 7 | 2024 |
| Endocrine disruptors and arterial hypertension: A developing story B Caroccia, I Caputo, FB Rossi, M Piazza, G Pallafacchina, GP Rossi Steroids 199, 109292, 2023 | 5 | 2023 |
| Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism F Torresan, FB Rossi, S Zanin, I Caputo, B Caroccia, M Iacobone, ... High Blood Pressure & Cardiovascular Prevention 31 (1), 15-21, 2024 | 1 | 2024 |
| Abstract P308: High Prevalence of Secondary Hypertension with Prospective Systematic Screening D Bagordo, T Shagjaa, FB ROSSI, G Pintus, C Zanon, E Bertoli, ... Hypertension 81 (Suppl_1), AP308-AP308, 2024 | | 2024 |
| Abstract P101: Surgical and not medical treatment of Primary Aldosteronism increase skin K+ levels: pathophysiological and clinical implications FB ROSSI, F Torresan, I Caputo, S Zanin, B Caroccia, G Bertoldi, ... Hypertension 81 (Suppl_1), AP101-AP101, 2024 | | 2024 |
| Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism G Rossitto, F Torresan, I Caputo, B Caroccia, G Bertoldi, FB Rossi, ... Journal of Hypertension 41 (Suppl 3), e37-e38, 2023 | | 2023 |
| Water and electrolyte content in HYpertension in the SKIn after surgical cure of primary-Aldosteronism (WHYSKI) FB Rossi, F Torresan, I Caputo, G Bertoldi, E Kohlscheen, B Caroccia, ... CLINICAL SCIENCE 137, 2023 | | 2023 |
